{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T02:24:59Z","timestamp":1792376699449,"version":"4.4.0"},"reference-count":38,"publisher":"Galenos Yayinevi","issue":"4","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk J Phys Med Rehab"],"accepted":{"date-parts":[[2025,10,8]]},"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:p>\n                    <jats:bold>Objectives:<\/jats:bold>\n                    This study aimed to evaluate the clinical efficacy of transfer energy capacitive and resistive (TECAR) therapy in females with Stage 2 lipedema, focusing on limb circumference, pain, functional status, and quality of life.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Patients and methods:<\/jats:bold>\n                    A prospective, randomized controlled trial was conducted with 30 female patients diagnosed with Stage 2 lipedema between September 2024 and May 2025. Participants were randomized to a TECAR group (n=15; mean age: 52.7\u00b113.1 years; range 39 to 66 years) or a control group (n=15; mean age: 45.9\u00b112.9 years; range, 37 to 59 years). Both groups received compression garments and a structured exercise program. The TECAR group additionally underwent six TECAR sessions over three weeks. Outcomes included lower limb circumference, Visual Analog Scale for pain, Lower Extremity Functional Scale, and Lymphedema Quality of Life Questionnaire-Leg, assessed at baseline and at one and three months after treatment.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    The groups were comparable at baseline for age (p=0.163) and body mass index (31.85\u00b14.08 kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    in the TECAR group and 30.02\u00b14.08 kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    in the control group; p=0.112). The TECAR therapy resulted in greater reductions in lower limb circumference compared to standard care, with a statistically significant and sustained improvement observed only in the supramalleolar region at three months (p&lt;0.05). A significant short-term reduction in pain was observed at one month (p=0.003) only in the TECAR group, but this effect was not maintained at three months (p&gt;0.05). Functional scores showed a nonsignificant trend toward improvement (p=0.058). The overall quality of life score improved significantly in the TECAR group (p=0.002), although no individual Lymphedema Quality of Life Questionnaire subdomain reached statistical significance (p&gt;0.05).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    As an adjunct to standard care, TECAR therapy appears to reduce pain and limb volume and enhance overall quality of life in Stage 2 lipedema. Further long-term studies are needed to confirm these findings.\n                  <\/jats:p>","DOI":"10.5606\/tftrd.2025.17157","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:31:38Z","timestamp":1764689498000},"page":"560-573","source":"Crossref","is-referenced-by-count":4,"title":["Clinical effects of TECAR therapy in the conservative management of Stage 2 lipedema in females: A randomized controlled trial"],"prefix":"10.4274","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3888-1064","authenticated-orcid":false,"given":"\u00d6znur","family":"Uzun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0246-3001","authenticated-orcid":false,"given":"Didem","family":"Sezgin \u00d6zcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6771-3265","authenticated-orcid":false,"given":"H\u00fcma","family":"B\u00f6l\u00fck \u015eenlik\u00e7i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0668-0544","authenticated-orcid":false,"given":"Zeynep","family":"Atalay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0791-6708","authenticated-orcid":false,"given":"R\u00fc\u00e7han","family":"\u00dcnal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7341-2888","authenticated-orcid":false,"given":"Meltem","family":"Dalyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Faerber G, Cornely M, Daubert C, Erbacher G, Fink J, Hirsch T, et al. S2k guideline lipedema. J Dtsch Dermatol Ges 2024;22:1303-15. doi: 10.1111\/ddg.15513.","DOI":"10.1111\/ddg.15513"},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Kruppa P, Georgiou I, Biermann N, Prantl L, KleinWeigel P, Ghods M. Lipedema-pathogenesis, diagnosis, and treatment options. Dtsch Arztebl Int 2020;117:396-403. doi: 10.3238\/arztebl.2020.0396.","DOI":"10.3238\/arztebl.2020.0396"},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Bertsch T, Erbacher G, Elwell R. Lipoedema: A paradigm shift and consensus. J Wound Care 2020;29:1-51. doi: 10.12968\/jowc.2020.29.Sup11b.1.","DOI":"10.12968\/jowc.2020.29.Sup11b.1"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Poojari A, Dev K, Rabiee A. Lipedema: Insights into morphology, pathophysiology, and challenges. Biomedicines 2022;10:3081. doi: 10.3390\/biomedicines10123081.","DOI":"10.3390\/biomedicines10123081"},{"key":"ref-5","unstructured":"Best Practice Guidelines: The Management of Lipoedema. London: Wounds UK; 2017. Available at: https:\/\/woundsuk.com\/wp-content\/uploads\/2023\/02\/450f55130cff8790118 8206fd115ccf3.pdf [Accessed: 02.11.2023]"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Kruppa P, Gohlke S, \u0141api\u0144ski K, Garcia-Carrizo F, Soultoukis GA, Infanger M, et al. Lipedema stage affects adipocyte hypertrophy, subcutaneous adipose tissue inflammation and interstitial fibrosis. Front Immunol 2023;14:1223264. doi: 10.3389\/fimmu.2023.1223264.","DOI":"10.3389\/fimmu.2023.1223264"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Felmerer G, Stylianaki A, H\u00e4gerling R, Wang A, Str\u00f6bel P, Hollm\u00e9n M, et al. Adipose tissue hypertrophy, an aberrant biochemical profile and distinct gene expression in lipedema. J Surg Res 2020;253:294-303. doi: 10.1016\/j. jss.2020.03.055.","DOI":"10.1016\/j.jss.2020.03.055"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Atan T, Bahar-\u00d6zdemir Y. The effects of complete decongestive therapy or intermittent pneumatic compression therapy or exercise only in the treatment of severe lipedema: A randomized controlled trial. Lymphat Res Biol 2021;19:86-95. doi: 10.1089\/lrb.2020.0019. .","DOI":"10.1089\/lrb.2020.0019"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Michelini S, Musa F, Vetrano M, Santoboni F, Nusca SM, Latini E, et al. Defocused and radial shock wave therapy, mesotherapy, and kinesio taping effects in patients with lipedema: A pilot study. Lymphology 2023;56:13-26.","DOI":"10.2458\/lymph.5872"},{"key":"ref-10","unstructured":"Peprah K, MacDougall D. Liposuction for the treatment of lipedema: a review of clinical effectiveness and guidelines [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Jun 7 [cited 2025 Jul 18]. Available at: https:\/\/www.ncbi.nlm.nih.gov\/books\/ NBK545818\/ [Accessed: 22.12.2023]"},{"key":"ref-11","unstructured":"Hawamdeh M. The effectiveness of capacitive resistive diathermy (Tecartherapy\u00ae) in acute and chronic musculoskeletal lesions and pathologies. Eur J Sci Res. 2014;118:336-40."},{"key":"ref-12","unstructured":"Ribeiro S, Henriques B, Cardoso R. The effectiveness of TECAR therapy in musculoskeletal disorders. Int J Public Health 2018;3:77-83."},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Cau N, Cimolin V, Aspesi V, Galli M, Postiglione F, Todisco A, et al. Preliminary evidence of effectiveness of TECAR in lymphedema. Lymphology 2019;52:35-43.","DOI":"10.2458\/lymph.4623"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Barassi G, Mariani C, Supplizi M, Prosperi L, Di Simone E, Marinucci C, et al. Capacitive and resistive electric transfer therapy: A comparison of operating methods in non-specific chronic low back pain. Adv Exp Med Biol 2022;1375:39-46. doi: 10.1007\/5584_2021_692.","DOI":"10.1007\/5584_2021_692"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Vahdatpour B, Haghighat S, Sadri L, Taghian M, Sadri S. Effects of transfer energy capacitive and resistive on musculoskeletal pain: A systematic review and metaanalysis. Galen Med J 2022;11:e2407. doi: 10.31661\/gmj. v11i.2407.","DOI":"10.31661\/gmj.v11i.2407"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Paolucci T, Pezzi L, Centra MA, Porreca A, Barbato C, Bellomo RG, et al. Effects of capacitive and resistive electric transfer therapy in patients with painful shoulder impingement syndrome: A comparative study. J Int Med Res 2020;48:300060519883090. doi: 10.1177\/0300060519883090.","DOI":"10.1177\/0300060519883090"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Uzun \u00d6, \u00d6zcan DSN, Arslan HB, Bilir EE, \u015eent\u00fcrk B, Tezen \u00d6. Impact of TECAR therapy on pain and function in adhesive capsulitis: A randomized controlled trial. Lasers Med Sci 2025;40:231. doi: 10.1007\/s10103-025-04492-x.","DOI":"10.1007\/s10103-025-04492-x"},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Niajalili M, Mohsen Roostayi M, Daryabor A, Naimi SS, Amoli MJ. The effect of Tecar therapy on neurological disorders and nerve conduction velocity of lower limbs in peripheral neuropathy of type 2 diabetic patients: A sixweek follow-up study. Turk J Phys Med Rehabil 2023;69:479- 87. doi: 10.5606\/tftrd.2023.11875.","DOI":"10.5606\/tftrd.2023.11875"},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Vahdatpour B, Ghasemi H, Taheri P. Effectiveness of TECAR therapy on clinical symptoms and neurophysiological parameters of patients with carpal tunnel syndrome: a randomized clinical trial. Middle East J Rehabil Health Stud. 2023;10:e134171.","DOI":"10.5812\/mejrh-134171"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Rueda L, Cabanas-Vald\u00e9s R, Salgueiro C, Rodr\u00edguezSanz J, P\u00e9rez-Bellmunt A, L\u00f3pez-de-Celis C. Immediate effects of TECAR therapy on gastrocnemius and quadriceps muscles with spastic hypertonia in chronic stroke survivors: A randomized controlled trial. Biomedicines 2023;11:2973. doi: 10.3390\/biomedicines11112973.","DOI":"10.3390\/biomedicines11112973"},{"key":"ref-21","unstructured":"Keith L, Seo C, Wahi MM, Huggins S, Carmody M, Faerber G, et al. Proposed framework for research case definitions of lipedema. Lymphat Res Biol 2024;22:93-105. doi: 10.1089\/ lrb.2023.0062."},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Czerwi\u0144ska M, Teodorczyk J, Spycha\u0142a D, HansdorferKorzon R. The usefulness of the application of compression therapy among lipedema patients-pilot study. Int J Environ Res Public Health 2023;20:914. doi: 10.3390\/ijerph20020914.","DOI":"10.3390\/ijerph20020914"},{"key":"ref-23","doi-asserted-by":"crossref","unstructured":"Amato ACM, Saucedo DZ, Santos KDS, Benitti DA. Ultrasound criteria for lipedema diagnosis. Phlebology 2021;36:651-8. doi: 10.1177\/02683555211002340.","DOI":"10.1177\/02683555211002340"},{"key":"ref-24","doi-asserted-by":"crossref","unstructured":"Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res (Hoboken) 2011;63 Suppl 11:S240-52. doi: 10.1002\/acr.20543.","DOI":"10.1002\/acr.20543"},{"key":"ref-25","doi-asserted-by":"crossref","unstructured":"Binkley JM, Stratford PW, Lott SA, Riddle DL. The Lower Extremity Functional Scale (LEFS): Scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network. Phys Ther 1999;79:371-83.","DOI":"10.1037\/t35109-000"},{"key":"ref-26","unstructured":"Keeley V, Crooks S, Locke J, Veigas D, Riches K, Hilliam R. A quality of life measure for limb lymphoedema (LYMQOL). J Lymphoedema 2010;5:26-37."},{"key":"ref-27","doi-asserted-by":"crossref","unstructured":"Borman P, Yaman A, Denizli M, Karahan S. The reliability and validity of lymphedema quality of life questionnaire-leg in Turkish patients with lower limb lymphedema. Lymphat Res Biol 2020;18:42-8. doi: 10.1089\/lrb.2018.0048.","DOI":"10.1089\/lrb.2018.0048"},{"key":"ref-28","doi-asserted-by":"crossref","unstructured":"Grewal T, Kempa S, Buechler C. Lipedema: A disease triggered by M2 polarized macrophages? Biomedicines 2025;13:561. doi: 10.3390\/biomedicines13030561.","DOI":"10.3390\/biomedicines13030561"},{"key":"ref-29","doi-asserted-by":"crossref","unstructured":"Clijsen R, Leoni D, Schneebeli A, Cescon C, Soldini E, Li L, et al. Does the application of tecar therapy affect temperature and perfusion of skin and muscle microcirculation? A pilot feasibility study on healthy subjects. J Altern Complement Med 2020;26:147-53. doi: 10.1089\/acm.2019.0165.","DOI":"10.1089\/acm.2019.0165"},{"key":"ref-30","doi-asserted-by":"crossref","unstructured":"Ida A, Neves E, Stadnik A. Effects of tecartherapy on body tissue: a systematic review. J Biomed Sci Eng 2023;16:133-48.","DOI":"10.4236\/jbise.2023.1610010"},{"key":"ref-31","doi-asserted-by":"crossref","unstructured":"Beltrame R, Ronconi G, Ferrara PE, Salgovic L, Vercelli S, Solaro C, et al. Capacitive and resistive electric transfer therapy in rehabilitation: A systematic review. Int J Rehabil Res 2020;43:291-8. doi: 10.1097\/ MRR.0000000000000435.","DOI":"10.1097\/MRR.0000000000000435"},{"key":"ref-32","unstructured":"Notarnicola A, Maccagnano G, Gallone MF, Covelli I, Tafuri S, Moretti B. Short term efficacy of capacitiveresistive diathermy therapy in patients with low back pain: A prospective randomized controlled trial. J Biol Regul Homeost Agents 2017;31:509-15."},{"key":"ref-33","doi-asserted-by":"crossref","unstructured":"Davari A, Sohani MS, Sarrafzadeh J, Nikjoui A. Evaluation of the effects of Tecar therapy on acute symptoms of athletes following lateral ankle ligament sprain. Funct Disabil J 2021;4:31-8.","DOI":"10.32598\/fdj.4.31"},{"key":"ref-34","doi-asserted-by":"crossref","unstructured":"Kudich E, Miha V, Kozinc \u017d. Effectiveness of TECAR therapy for managing pain in sports-related musculoskeletal pathologies: a systematic review with meta-analysis. SN Compr Clin Med 2025;7:28.","DOI":"10.1007\/s42399-025-01794-7"},{"key":"ref-35","doi-asserted-by":"crossref","unstructured":"Herbst KL, Kahn LA, Iker E, Ehrlich C, Wright T, McHutchison L, et al. Standard of care for lipedema in the United States. Phlebology 2021;36:779-96. doi: 10.1177\/02683555211015887.","DOI":"10.1177\/02683555211015887"},{"key":"ref-36","doi-asserted-by":"crossref","unstructured":"G\u0142owacka J, Tekiela N, Papachristoforou N, Micha\u0142ka D. Lipedema: diagnosis, treatment and the vicious cycle-a review of the literature. Qual Sport 2025;38:57746.","DOI":"10.12775\/QS.2025.38.57746"},{"key":"ref-37","doi-asserted-by":"crossref","unstructured":"Sakizli Erdal E, Ergin C, Haspolat M, Erturk B, Keser I. Effects of multimodal exercise program on edema, pain, exercise capacity, lower extremity muscle strength and function in patients with lipedema. Phlebology 2025:2683555251343148. doi: 10.1177\/02683555251343148.","DOI":"10.1177\/02683555251343148"},{"key":"ref-38","doi-asserted-by":"crossref","unstructured":"Alwardat N, Di Renzo L, Alwardat M, Romano L, De Santis GL, Gualtieri P, et al. The effect of lipedema on healthrelated quality of life and psychological status: A narrative review of the literature. Eat Weight Disord 2020;25:851-6. doi: 10.1007\/s40519-019-00703-x.","DOI":"10.1007\/s40519-019-00703-x"}],"container-title":["Turkish Journal of Physical Medicine and Rehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4624.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4624.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:08:39Z","timestamp":1783066119000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ftrdergisi.com\/uploads\/pdf\/pdf_4624.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":38,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.5606\/tftrd.2025.17157","relation":{},"ISSN":["2587-1250"],"issn-type":[{"value":"2587-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]}}}